Baker Bros. Advisors »

Cerevel Therapeutics Hldng I shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $68M 1.6M 42.40

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeiGene Sponsored Adr (BGNE)
ACADIA Pharmaceuticals (ACAD)
Madrigal Pharmaceuticals (MDGL)
Rhythm Pharmaceuticals (RYTM)
Mirati Therapeutics
Immunocore Holdings Ads (IMCR)
Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Invitae Corporation Notes 1.5% 4/1/2028 (Principal)
Abcellera Biologics (ABCL)
Roivant Sciences SHS (ROIV)
Replimune Group (REPL)
Entrada Therapeutics (TRDA)
Ultragenyx Pharmaceutical (RARE)

View all positions for Baker Bros. Advisors

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I